Guide · 2026
OECD Health Systems Compared
Healthcare spending, physician density, hospital capacity, life expectancy, and infant mortality across all 38 OECD member countries, with live data from OECD Health Statistics 2025.
Key Finding
OECD countries spend an average of 9.1% of GDP on healthcare, equating to about $5,462 per person per year. The United States spends nearly twice the OECD average per capita yet achieves lower life expectancy than most comparable members — the clearest illustration that healthcare spending volume and health outcomes are not the same thing.
Life Expectancy Across OECD Countries
The OECD average life expectancy at birth is 81.1 years as of the most recent data. Switzerland, Japan, Spain, Israel, and Italy lead the group — all above 83 years — while Mexico, Latvia, and Hungary sit at the lower end, below 77 years. The roughly 9-year spread within this club of wealthy nations reflects meaningful differences in healthcare access, lifestyle factors, diet, and the prevalence of chronic conditions.
A key pattern: European countries with universal healthcare systems and Mediterranean diets (Spain, Italy, France) achieve life expectancy at or above countries that spend substantially more. Japan and South Korea demonstrate that East Asian dietary norms and cultural health behaviors can produce strong outcomes even with physician density at the lower end of OECD peers.
Top 5 by Life Expectancy (OECD, 2023)
| # | Country | Life Expectancy |
|---|---|---|
| 1 | Switzerland | 84.3 yrs |
| 2 | Japan | 84.1 yrs |
| 3 | Spain | 84.0 yrs |
| 4 | Israel | 83.8 yrs |
| 5 | Italy | 83.5 yrs |
| OECD average | 81.1 yrs |
Healthcare Spending: Volume vs. Efficiency
Health spending as a share of GDP ranges from around 4–5% in Turkey and Luxembourg to nearly 17% in the United States. The OECD average sits at 9.1% of GDP. In per-capita terms (adjusted for purchasing power), the range is even more stark: the US spends over $13,800 per person annually, while Turkey and Mexico spend roughly $1,000–2,000.
High spending does not guarantee good outcomes. The United States is the canonical example: highest per-capita spending in the OECD, yet below-average life expectancy among high-income members. Several factors explain this gap — administrative overhead from a fragmented multi-payer system, higher prices for identical drugs and procedures, and high rates of preventable conditions related to obesity and lifestyle. By contrast, countries like Spain and South Korea achieve above-average outcomes at moderate spending levels.
Highest Healthcare Spending (% GDP)
| Country | % GDP |
|---|---|
| United States | 16.7% |
| Germany | 11.7% |
| Switzerland | 11.7% |
| France | 11.5% |
| Sweden | 11.3% |
Lowest Healthcare Spending (% GDP)
| Country | % GDP |
|---|---|
| Turkiye | 4.3% |
| Luxembourg | 5.7% |
| Mexico | 5.7% |
| Hungary | 6.4% |
| Ireland | 6.6% |
Physician Density and Hospital Capacity
The OECD average is 3.9 physicians per 1,000 people. Austria leads with 5.5 per 1,000; Italy, Norway, and Germany also rank near the top at 4.7–5.4. Japan, South Korea, and Mexico have the lowest physician ratios among OECD members (around 2.7), yet Japan and Korea achieve the highest life expectancy — demonstrating that physician density interacts with other system factors.
Hospital bed capacity tells a different story. South Korea and Japan dominate with over 12 beds per 1,000 people — more than triple the OECD average of 4.2. This reflects a system model built around inpatient care and longer hospital stays. Western European countries have deliberately reduced bed counts over recent decades as care shifted toward outpatient settings, without sacrificing outcomes.
Infant Mortality: The Sharpest Health Equity Measure
Infant mortality — deaths in the first year of life per 1,000 live births — is one of the most sensitive measures of a healthcare system's reach. Among OECD countries, the range runs from under 2 per 1,000 (Estonia, Finland, Japan, Slovenia) to over 9–16 per 1,000 in Colombia, Mexico, and Turkey. Even within this wealthy-country group, a child born in the highest-mortality member faces a death risk more than 8 times greater than in the lowest-mortality member.
The United States records about 5.4 infant deaths per 1,000 live births — notably higher than most Western European peers — despite its high total healthcare spending. Research points to several factors: socioeconomic disparities in access to prenatal care, higher rates of preterm birth, and inequities in maternal healthcare across demographic groups.
Vaccination Coverage as a System Health Signal
Vaccination rates — specifically DTP (diphtheria, tetanus, pertussis) and measles coverage — serve as proxies for healthcare system reach and function. Maintaining 95%+ coverage requires working supply chains, trained healthcare workers, and effective outreach. Most OECD countries achieve 90–99% DTP3 coverage, though several members show rates below 90%, reflecting challenges with hesitancy or access in specific populations.
Measles vaccination coverage is particularly important given the virus's high transmissibility. The OECD benchmark of 95% herd immunity threshold has not been achieved uniformly — some members report measles vaccination rates in the 80–85% range, creating vulnerability to outbreaks.
Comparing Healthcare Efficiently vs. By Spending
When comparing health systems, two different frameworks apply:
- Outcomes per dollar spent: Dividing life expectancy or infant mortality by health spending per capita reveals efficiency. Japan, South Korea, and Spain achieve excellent outcomes at well below the US spending level — their systems deliver more health per dollar invested.
- Universal access vs. selective access: Countries with universal coverage systems (nearly all OECD members except the US for much of the 20th century) benefit from earlier intervention, better chronic disease management, and lower rates of catastrophic health expenditures for individuals.
- Preventive vs. curative orientation: Systems that invest heavily in primary care and preventive services tend to have lower chronic disease burden long-term, but the benefits accumulate slowly. Countries with strong family medicine infrastructure (Netherlands, Denmark, Australia) often achieve good outcomes through primary care emphasis.
- Capacity vs. utilization: Korea and Japan have very high hospital bed capacity and high utilization rates. Nordic countries have lower capacity but tight coordination between primary and secondary care. Both approaches can work — what matters is how well the system is integrated and coordinated.
Explore these trade-offs by comparing specific OECD countries side by side: US vs UK, Germany vs France, or Japan vs South Korea.
Frequently Asked Questions
Which OECD country has the best healthcare system?
No single country tops every measure, but Switzerland, Japan, Spain, and Australia consistently rank near the top for life expectancy (all above 83 years) while maintaining relatively efficient spending. The United States spends by far the most per capita — over $13,800 per person in 2023 — yet achieves lower life expectancy than most other high-income OECD members, illustrating that spending volume alone does not determine outcomes.
Why does the United States spend so much more on healthcare than other OECD countries?
The US spends approximately 16.7% of GDP on healthcare — nearly double the OECD average of about 9%. Multiple structural factors contribute: higher prices for the same drugs and procedures, administrative complexity from a fragmented multi-payer system, higher labor costs for healthcare workers, and significant spending on conditions associated with obesity, substance use disorders, and firearm injuries. Unlike other high-income countries, the US lacks universal coverage, meaning a large share of spending addresses preventable and delayed-care situations.
What does "physicians per 1,000 population" actually measure?
This indicator counts practicing physicians (those actively delivering care to patients) per 1,000 residents. It reflects healthcare capacity — how many doctors are available to serve the population. Austria leads OECD members with about 5.5 physicians per 1,000 people; Japan and Korea have among the lowest ratios (around 2.7) yet achieve excellent outcomes, partly through high hospital capacity (beds) and preventive care culture. A low ratio is not necessarily bad if supported by other system elements.
How is OECD health spending data measured?
OECD health expenditure data follows the System of Health Accounts (SHA) methodology, which categorizes all health spending by function (curative care, preventive care, administration, etc.), financing scheme (government, private insurance, out-of-pocket), and provider. The data includes both government and private spending. Per capita figures are expressed in US dollars adjusted for purchasing power parity (PPP) to allow meaningful cross-country comparison. Data is collected annually by OECD from national health authorities.
What is the DTP vaccination rate and why does it matter?
The DTP3 vaccination rate measures the share of children who received all three doses of the diphtheria, tetanus, and pertussis vaccine. It is the most widely used coverage benchmark because the three-dose schedule requires sustained engagement with the healthcare system — supply chains, trained workers, and parental access. Countries achieving 95%+ coverage have proven their primary healthcare systems can reliably reach most of the population, a capability that matters for all preventive care.
Why do hospital bed numbers vary so much across OECD countries?
South Korea and Japan have over 12 hospital beds per 1,000 people — the highest in the OECD — while countries like Mexico and some Nordic nations have fewer than 3. The variation reflects both historical patterns and deliberate policy choices. Countries with high bed counts often have longer average lengths of stay and more inpatient-oriented care models. Many Western European countries have shifted toward ambulatory (outpatient) care, reducing bed counts intentionally while maintaining or improving outcomes. Bed counts alone don't indicate quality.
Sources
- OECD Health Statistics 2025 — physicians, nurses, beds, life expectancy, infant mortality, vaccination, health spending
- OECD Health at a Glance 2023 — comparative analysis and country notes
- World Bank — World Development Indicators (cross-reference for GDP and population)
- WHO Global Health Observatory — supplementary mortality and disease data
Data from OECD Health Statistics 2025. Country values represent the most recent year available per indicator. OECD averages are unweighted means across reporting members. This guide is for informational purposes only.
Explore the data: Full OECD health rankings · Compare any two countries · Global health indicators guide
Understanding the Data
The information presented throughout this guide is informed by publicly available public records published by federal and state government agencies. Our database aggregates and standardizes these records to make them more accessible and easier to interpret for general audiences. When we reference specific statistics or trends, they are drawn directly from these authoritative sources unless explicitly noted otherwise.
It is important to understand the limitations of any large-scale data dataset. Records may contain errors from the original data collection process, some fields may be incomplete for older entries, and classification systems may have changed over time. Our analysis accounts for these factors by clearly labeling data vintage, flagging records with missing critical fields, and noting when temporal comparisons span methodology changes in the source data.
For readers who want to conduct their own research, we recommend going directly to the source whenever possible. federal and state government agencies provides detailed documentation on collection methodology, sampling frames, and known data quality issues. Our goal is not to replace primary sources but to make them more approachable and to highlight patterns that may not be immediately obvious when browsing raw records.
How We Analyze Data Records
Our analytical approach involves several steps designed to surface meaningful insights from large datasets. First, we clean and standardize the raw data, handling variations in naming conventions, date formats, and categorical labels. Then we compute summary statistics, distributions, and comparative benchmarks across relevant dimensions such as geography, time period, and category type.
Key metrics we examine include statistical records, geographic distributions, temporal trends. These indicators provide a multi-dimensional view of each entity in our database, allowing users to understand not just individual records but how they compare to peers, regional averages, and national benchmarks. We believe this contextual approach is far more valuable than presenting raw numbers in isolation.